Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common stock, $0.08 par value
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
73,359
-
Shares change
-
+57,722
-
Total reported value, excl. options
-
$79,938
-
Value change
-
+$63,904
-
Number of buys
-
3
-
Price
-
$1.08
Significant Holders of China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC) as of Q2 2024
6 filings reported holding SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value as of Q2 2024.
China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73,359 shares
.
Largest 6 shareholders include Virtu Financial LLC (31,607 shares), CITADEL ADVISORS LLC (16,115 shares), UBS Group AG (12,575 shares), BANK OF MONTREAL /CAN/ (10,000 shares), ACADIAN ASSET MANAGEMENT LLC (2,759 shares), and Qube Research & Technologies Ltd (303 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.